Patients with severe immunosuppression, indicated by nadir CD4 counts below 50 cells/mm3, more frequently present with advanced-stage lymphomas (stages III/IV) and systemic symptoms, complicating management and worsening outcomes. The gene discussed is CD4; the disease is lymphoma.